DPP4 and metabolic dysfunction-associated steatotic liver disease: Studies investigating hepatic or circulating DPP4 levels in relation to the presence of NAFLD in humans, found controversial results [13, 14, 16, 17]; furthermore, no evidence on the contextual expression of DPP4 mRNA in the liver, along with the measurement of its plasma concentration and activity is available yet.